Association of Plasma Aflatoxin with Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples from Kenyan Women Enrolled in a Longitudinal Study

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2023 Jun 6

PMID 37280534

Authors

Yan Tong

Philip Tonui

Omenge Orango

Jianjun Zhang

Titus Maina

Kapten Muthoka

John Groopman

Joshua Smith

Erin Madeen

Aaron Ermel

Patrick Loehrer

Darron R Brown

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer is caused by oncogenic human papillomaviruses (HR-HPV) and is common among Kenyan women. Identification of factors that increase HR-HPV persistence is critically important. Kenyan women exposed to aflatoxin have an increased risk of HR-HPV detection in cervical specimens. This analysis was performed to examine associations between aflatoxin and HR-HPV persistence.

Methods: Kenyan women were enrolled in a prospective study. The analytical cohort for this analysis included 67 HIV-uninfected women (mean age 34 years) who completed at least two of three annual study visits and had an available blood sample. Plasma aflatoxin was detected using ultra-high pressure liquid chromatography (UHPLC)-isotope dilution mass spectrometry. Annual cervical swabs were tested for HPV (Roche Linear Array). Ordinal logistic regression models were fitted to examine associations of aflatoxin and HPV persistence.

Results: Aflatoxin was detected in 59.7% of women and was associated with higher risk of persistent detection of any HPV type (OR = 3.03, 95%CI = 1.08-8.55, P = 0.036), HR-HPV types (OR = 3.63, 95%CI = 1.30-10.13, P = 0.014), and HR-HPV types not included in the 9-valent HPV vaccine (OR = 4.46, 95%CI = 1.13-17.58, P = 0.032).

Conclusions: Aflatoxin detection was associated with increased risk of HR-HPV persistence in Kenyan women. Further studies, including mechanistic studies are needed to determine if aflatoxin synergistically interacts with HR-HPV to increase cervical cancer risk.

References

Kjaer S, Frederiksen K, Munk C, Iftner T . Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010; 102(19):1478-88. PMC: 2950170. DOI: 10.1093/jnci/djq356. View

Stelzle D, Tanaka L, Lee K, Ibrahim Khalil A, Baussano I, Shah A . Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020; 9(2):e161-e169. PMC: 7815633. DOI: 10.1016/S2214-109X(20)30459-9. View

. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2008; 90:1-636. PMC: 4781057. View

Zhang J, Orango O, Tonui P, Tong Y, Maina T, Kiptoo S . Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women. Open Forum Infect Dis. 2019; 6(9). PMC: 6736060. DOI: 10.1093/ofid/ofz354. View

Mwenda V, Mburu W, Bor J, Nyangasi M, Arbyn M, Weyers S . Cervical cancer programme, Kenya, 2011-2020: lessons to guide elimination as a public health problem. Ecancermedicalscience. 2022; 16:1442. PMC: 9470178. DOI: 10.3332/ecancer.2022.1442. View

Shirani K, Zanjani B, Mahmoudi M, Jafarian A, Hassani F, Giesy J . Immunotoxicity of aflatoxin M : as a potent suppressor of innate and acquired immune systems in a subacute study. J Sci Food Agric. 2018; 98(15):5884-5892. DOI: 10.1002/jsfa.9240. View

Ermel A, Shew M, Imburgia T, Brown M, Qadadri B, Tong Y . Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life. Papillomavirus Res. 2018; 5:75-79. PMC: 5886910. DOI: 10.1016/j.pvr.2018.01.001. View

Chirwa G . Explaining socioeconomic inequality in cervical cancer screening uptake in Malawi. BMC Public Health. 2022; 22(1):1376. PMC: 9295286. DOI: 10.1186/s12889-022-13750-4. View

Smith J, Kroker-Lobos M, Lazo M, Rivera-Andrade A, Egner P, Wedemeyer H . Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. PLoS One. 2017; 12(12):e0189255. PMC: 5728519. DOI: 10.1371/journal.pone.0189255. View

10.

Groopman J, Kensler T, Wild C . Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu Rev Public Health. 2007; 29:187-203. DOI: 10.1146/annurev.publhealth.29.020907.090859. View

11.

Watson S, Moore S, Darboe M, Chen G, Tu Y, Huang Y . Impaired growth in rural Gambian infants exposed to aflatoxin: a prospective cohort study. BMC Public Health. 2018; 18(1):1247. PMC: 6234772. DOI: 10.1186/s12889-018-6164-4. View

12.

Turner P, Moore S, Hall A, Prentice A, Wild C . Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Perspect. 2003; 111(2):217-20. PMC: 1241353. DOI: 10.1289/ehp.5753. View

13.

Sipos P, Peles F, Brasso D, Beri B, Pusztahelyi T, Pocsi I . Physical and Chemical Methods for Reduction in Aflatoxin Content of Feed and Food. Toxins (Basel). 2021; 13(3). PMC: 7999035. DOI: 10.3390/toxins13030204. View

14.

Rushing B, Selim M . Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods. Food Chem Toxicol. 2018; 124:81-100. DOI: 10.1016/j.fct.2018.11.047. View

15.

Gravitt P . Evidence and impact of human papillomavirus latency. Open Virol J. 2013; 6:198-203. PMC: 3547385. DOI: 10.2174/1874357901206010198. View

16.

Liu G, Sharma M, Tan N, Barnabas R . HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018; 32(6):795-808. PMC: 5854529. DOI: 10.1097/QAD.0000000000001765. View

17.

Chu Y, Yang H, Wu H, Lee M, Liu J, Wang L . Aflatoxin B exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Eur J Cancer. 2018; 94:37-46. PMC: 5895495. DOI: 10.1016/j.ejca.2018.02.010. View

18.

Groopman J, Egner P, Schulze K, Wu L, Merrill R, Mehra S . Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B₁-lysine albumin biomarkers. Food Chem Toxicol. 2014; 74:184-9. PMC: 4322911. DOI: 10.1016/j.fct.2014.09.016. View

19.

McCoy L, Scholl P, Sutcliffe A, Kieszak S, Powers C, Rogers H . Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry. Cancer Epidemiol Biomarkers Prev. 2008; 17(7):1653-7. DOI: 10.1158/1055-9965.EPI-07-2780. View

20.

Ba D, Ssentongo P, Musa J, Agbese E, Diakite B, Traore C . Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiol. 2021; 72:101930. PMC: 8864323. DOI: 10.1016/j.canep.2021.101930. View